Baecher-allan, C., Kaskow, B. J., & Weiner, H. L. (2018). Review Multiple Sclerosis :
Mechanisms and Immunotherapy. Neuron, 97(4), 742–768. Recuperado de:
Castillero, O. (2019). Esclerosis Múltiple: tipos, síntomas y posibles causas. Recuperado de:
Chung, K. K., Altmann, D., Barkhof, F., Miszkiel, K., Hons, B. M., Brex, P. A.,
Chard, D. T. (2019). A 30-Year Clinical and Magnetic Resonance Imaging
Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes,
63–74. Recuperado de: https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25637
Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017). “brain sciences Multiple
Sclerosis : Immunopathology and Treatment Update”, 1–27. Recuperado de:
Dobson, R., Giovannoni, G. (2018) “Multiple Sclerosis - a review” European Journal of
Neurology. Vol 26, issue 1. Recuperado de:
Fundación de Esclerosis Múltiple de Puerto Rico. (n.d.). Retrieved May 1, 2020, from: http://www.fempr.org/fundacion.htm
Ghasemi, N., Razavi, S., & Nikzad, E. (2017). Multiple Sclerosis: Pathogenesis,
Symptoms, Diagnoses and Cell-Based Therapy. Cell journal, 19(1), 1–10.
Recuperado de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241505/
Giovannoni, G. (Director). (2017). Pathophysiology of MS [Video file]. Retrieved 2020, from: https://www.youtube.com/watch?v=dv4khyfaNuw&t=1s
González Rodríguez, M. (2018). Esclerosis múltiple: últimos avances. (Trabajo Fin de
Grado Inédito). Universidad de Sevilla, Sevilla.
Huang, W. J., Chen, W. W., & Zhang, X. (2017). Multiple sclerosis: Pathology, diagnosis
and treatments. Experimental and therapeutic medicine, 13(6), 3163–3166.
Recuperado de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450788/
Katz Sand, I. (2018, September). The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132382/
Marín, M. I., de la Valle, M., y Flores, L. (2020). ¿Qué aporta realmente la terapia acuática a la esclerosis múltiple a través de la terapia ocupacional? RIAA. Revista de Investigación en Actividades Acuáticas, 4(7), 18-26. https://doi.org/10.21134/riaa.v4i7.1719
Mayo Clinic (2019) “Esclerosis Multiple”. Recuperado de:
Mayo Clinic. (2019). MRI multiple sclerosis lesions. Retrieved May 02, 2020, from
MedlinePlus. (2020). Reflejo de Babinski: MedlinePlus enciclopedia médica. Retrieved May 02, 2020, from https://medlineplus.gov/spanish/ency/article/003294.htm
Mohamed, K., & Koriem, M. (2016). “Multiple Sclerosis: New insights and Trends”
Asian Pacific Journal of Tropical Biomedicine. Asian Pacific Journal of Tropical
Biomedicine, 6(5), 429–440. Recuperado de:
MSP (2017) “Los municipios con mas casos de esclerosis multiple en Puerto Rico”.
Medicina Salud Publica. Recuperado de:
Multiple Sclerosis Association of America. (2020). The Immune System and Multiple
Sclerosis. Retrieved from:
Ósmosis. (2017, March 22). "Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology" [Video file]. Recuperado de: https://www.youtube.com/watch?v=yzH8ul5PSZ8
Reish, D., M.D., Ph.D, Lucchinetti, C., M.D., and Calabresi, P., M.D. (2018) “Multiple
Sclerosis”. The new England Journal of Medicine. 378: 169-180. Recuperado de:
Sá, M. J., Kobelt, G., Berg, J., Capsa, D., & Dalén, J. (2017). New insights into the
burden and costs of multiple sclerosis in Europe: Results for Portugal, (July).
Recuperado de:
Statista Research Department (2015) “Esclerosis multiple por cada 100,000 individuos en
Estados Unidos a fecha de 2015 por regiones” Recuperado de:
Sullivan, D. (2018). Multiple Sclerosis: Facts, Statistics, and You. Recuperado de:
Torres Pareja, M. (2019). Estudio de la influencia de la actividad física y la fatiga en personas con Esclerosis Múltiple. [PDF]. Toledo.
Why is MS more common in women? Study explains why. (2014, May 8). Retrieved from:
Wu, G. F., & Alvarez, E. (2011). The immunopathophysiology of multiple sclerosis.
Neurologic clinics, 29(2), 257–278. https://doi.org/10.1016/j.ncl.2010.12.009
Recuperado de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080042/
Zhang, G. (2013, July 8). Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Retrieved from: